Innate Pharma Sa (IPHA) Annual Balance Sheets

Annual · GAAP · USD millions
Access IPHA quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Innate Pharma Sa's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents31.46
Cash & Short-term Investments31.00
Trade & Other Current Receivables (IFRS combined total)14.55
Other Current Assets20.85
Total Current Assets52.32
Equipment/Property/Plant Net0.00
Deferred Tax Assets0.00
Other Assets, Noncurrent17.93
Trade And Other Current Receivables13.89
Noncurrent Assets-
Noncurrent Financial Assets11.71
Other Noncurrent Nonfinancial Assets1.06
Total Assets70.25
Liabilities
Other Liabilities, Current37.15
Current Provisions3.90
Total Current Liabilities41.05
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Noncurrent Provisions0.37
Trade And Other Current Payables16.85
Current Financial Liabilities9.86
Total Liabilities41.42
Stockholders' Equity
Noncurrent Financial Liabilities15.42
Other Equity-39.73
Common Stockholder's Equity-24.31
Total Stockholder's Equity-24.31
Liabilities & Stockholder's Equity73.61
4 historic quarters locked

Sign in to unlock the full Innate Pharma Sa balance sheet history.

About Innate Pharma Sa Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001598599-26-000005

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License